Inhibitor Therapeutics, Inc. (INTI) Press Releases https://investors.inhibitortx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_5a8cb0b9c83c9803ac6e80d95e72f0b2/inhibitortx/files/theme/images/logo-sm.png Inhibitor Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome]]> https://investors.inhibitortx.com/news-events/press-releases/detail/11/inhibitor-therapeutics-provides-clinical-formulation-and-ip-update-on-itraconazole-program-for-gorlin-syndrome Tue, 31 Mar 26 15:44:00 -0400 https://investors.inhibitortx.com/news-events/press-releases/detail/11/inhibitor-therapeutics-provides-clinical-formulation-and-ip-update-on-itraconazole-program-for-gorlin-syndrome <![CDATA[Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan]]> https://investors.inhibitortx.com/news-events/press-releases/detail/10/inhibitor-therapeutics-inc-provides-update-on-its-clinical-development-plan Thu, 22 Aug 24 09:00:00 -0400 https://investors.inhibitortx.com/news-events/press-releases/detail/10/inhibitor-therapeutics-inc-provides-update-on-its-clinical-development-plan <![CDATA[Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board]]> https://investors.inhibitortx.com/news-events/press-releases/detail/5/introducing-inhibitor-therapeutics-inc-new-scientific-advisory-board Tue, 19 Dec 23 10:00:00 -0500 https://investors.inhibitortx.com/news-events/press-releases/detail/5/introducing-inhibitor-therapeutics-inc-new-scientific-advisory-board <![CDATA[Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University]]> https://investors.inhibitortx.com/news-events/press-releases/detail/6/inhibitor-therapeutics-inc-exclusive-license-with-johns-hopkins-university Wed, 13 Dec 23 15:43:00 -0500 https://investors.inhibitortx.com/news-events/press-releases/detail/6/inhibitor-therapeutics-inc-exclusive-license-with-johns-hopkins-university <![CDATA[INHIBITOR Therapeutics Receives prostate cancer IND Clearance from FDA]]> https://investors.inhibitortx.com/news-events/press-releases/detail/7/inhibitor-therapeutics-receives-prostate-cancer-ind-clearance-from-fda Wed, 22 Jan 20 08:05:00 -0500 https://investors.inhibitortx.com/news-events/press-releases/detail/7/inhibitor-therapeutics-receives-prostate-cancer-ind-clearance-from-fda <![CDATA[INHIBITOR Therapeutics Submits Investigational New Drug Application for Treatment of Patients with Late-Stage Prostate Cancer]]> https://investors.inhibitortx.com/news-events/press-releases/detail/8/inhibitor-therapeutics-submits-investigational-new-drug-application-for-treatment-of-patients-with-late-stage-prostate-cancer Mon, 25 Nov 19 07:33:00 -0500 https://investors.inhibitortx.com/news-events/press-releases/detail/8/inhibitor-therapeutics-submits-investigational-new-drug-application-for-treatment-of-patients-with-late-stage-prostate-cancer <![CDATA[INHIBITOR Therapeutics Appoints Dr. Debra Peattie to its Board of Directors]]> https://investors.inhibitortx.com/news-events/press-releases/detail/9/inhibitor-therapeutics-appoints-dr-debra-peattie-to-its-board-of-directors Thu, 31 Oct 19 08:55:00 -0400 https://investors.inhibitortx.com/news-events/press-releases/detail/9/inhibitor-therapeutics-appoints-dr-debra-peattie-to-its-board-of-directors